Novartis

Novartis Dividend

The Dividend of Novartis (NOVN.SW) as of Oct 27, 2026 is 4.24 USD. In the previous year, Dividend was 4.00 USD — a change of 6.06% (higher).

Dividend

4.24USD

YoY

6.06%

Dividend yield

2.26 %

Last updated:

How much dividend does Novartis 2026 pay?

According to the latest status from October 2026, Novartis paid a total of 4.24 USD per share in dividends within the last 12 months. With the current Novartis price of 154.82 USD, this corresponds to a dividend yield of 2.25 %. A dividend is paid times per year.

Novartis currently offers a dividend yield of about 2.26%. The payout ratio is around 69% of earnings. The dividend has grown at 7.1% per year over the past 19 years.

Historical Novartis Dividends

A dividend is paid times per year. Last year, the payout months were and April.

Historical Novartis Dividends
PaydateDividend
3.70USD
3.50USD
3.30USD
2.67USD
2.58USD
2.50USD
2.46USD
2.38USD
2.33USD
2.29USD
2.25USD
2.17USD
2.04USD
1.92USD
1.88USD
1.83USD
1.75USD
1.67USD
1.33USD
1.13USD
0.96USD
0.88USD
0.83USD
0.79USD
0.75USD
0.71USD
0.67USD
0.60USD
0.52USD
0.42USD

The Novartis Dividend history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Dividend
Date
Dividend
Jan 1, 2023
3.23 USD
Jan 1, 2024
4.00 USD
Jan 1, 2025
4.24 USD
Jan 1, 2026 (e)
3.70 USD
Jan 1, 2027 (e)
4.00 USD
Jan 1, 2028 (e)
4.33 USD
Jan 1, 2029 (e)
4.68 USD
Jan 1, 2030 (e)
5.06 USD
The Novartis Dividend history
YEARDividendYoY
est5.06USD+8.16%
est4.68USD+8.16%
est4.33USD+8.16%
est4.00USD+8.16%
est3.70USD-12.82%
4.24USD+6.06%
4.00USD+23.75%
3.23USD+3.23%
3.13USD+3.33%
3.03USD+1.70%
2.98USD+3.51%
2.88USD+1.79%
2.83USD+1.82%
2.78USD+1.85%
2.73USD+3.84%
2.63USD+6.12%
2.48USD+29.17%
1.92USD+2.22%
1.88USD+2.27%
1.83USD+4.76%
1.75USD+5.00%
1.67USD+25.01%
1.33USD+18.52%
1.13USD+17.40%
0.96USD—

Novartis dividend history and estimates

In 2025, Novartis paid a dividend amounting to 3.50 USD. Dividend means that Novartis distributes a portion of its profits to its owners.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Dividend
Details
Date
Dividend
Dividend (Estimate)
Jan 1, 2021
2.50 USD
0.00 USD
Jan 1, 2022
2.58 USD
0.00 USD
Jan 1, 2023
2.67 USD
0.00 USD
Jan 1, 2024
3.30 USD
0.00 USD
Jan 1, 2025
3.50 USD
0.00 USD
Jan 1, 2026
3.70 USD
0.00 USD
Jan 1, 2027 (e)
0.00 USD
4.00 USD
Jan 1, 2028 (e)
0.00 USD
4.33 USD

Is the Novartis Dividend Safe?

Novartis has been increasing the dividend for 19 years.

Over the past 10 years, Novartis has increased it by an annual 4.91%.

Over a five-year period, the distribution rose by 7.32%.

Analysts expect a Dividend Increase of 2.82% for the current fiscal year.

Novartis dividend payout ratio

In 2025, Novartis had a payout ratio of 68.67%. The payout ratio indicates the percentage of the company's profits that Novartis distributes as dividends.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Payout ratio
Details
Date
Payout ratio
Jan 1, 2021
34.94 %
Jan 1, 2022
118.99 %
Jan 1, 2023
55.26 %
Jan 1, 2024
82.52 %
Jan 1, 2025
68.67 %
Jan 1, 2026 (e)
42.22 %
Jan 1, 2027 (e)
40.96 %
Jan 1, 2028 (e)
40.30 %

Dividend Details

Understanding Novartis's Dividend Distributions

Novartis’s dividends are a portion of the company’s profits distributed to shareholders. It is a critical indicator of the company’s financial health and attractiveness to investors. Dividends provide investors with a steady income stream, in addition to any profits that may come from selling the stock at a higher price than the purchase price.

Year-to-Year Comparison

Examining Novartis's dividend distributions over the years can highlight the company’s profitability and stability. A consistent or increasing dividend payout can indicate a financially healthy company with predictable earnings, while fluctuations or reductions in dividends can suggest underlying financial or operational challenges.

Impact on Investments

Novartis's dividend payments are an essential factor for income-focused investors. A robust dividend payout can enhance the stock’s appeal, offering regular income in addition to potential capital gains. It also can indicate the company's confidence in its future earnings, making it a significant consideration in investment decisions.

Interpreting Dividend Fluctuations

Changes in Novartis’s dividends can result from shifts in the company’s earnings, financial policies, or reinvestment strategies. An increase in dividends often signals financial stability, while a decrease may indicate a need to conserve cash or reinvest profits to fuel growth, each scenario having different implications for investors.

Novartis Stock analysis

What does Novartis do? Novartis AG is a globally active company operating in the pharmaceutical, ophthalmology, and generics manufacturing sectors. The company, headquartered in Basel, Switzerland, was founded in 1996 and originated from a merger between Ciba-Geigy and Sandoz. Novartis AG is now a leading company worldwide in the research, development, production, and marketing of pharmaceuticals and other health products. Novartis is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Novartis stock

Over the past 12 months, Novartis paid a dividend of 3.50 USD . This corresponds to a dividend yield of about 2.26 %. For the coming 12 months, Novartis is expected to pay a dividend of 4.00 USD.

The current dividend yield of Novartis is 2.26 %.

Novartis pays a dividend, distributed in the months of March.

Novartis paid dividends every year for the past 29 years.

For the upcoming 12 months, dividends amounting to 4.00 USD are expected. This corresponds to a dividend yield of 2.58 %.

Novartis is assigned to the 'Health' sector.

To receive the latest dividend of Novartis from 3/12/2026 amounting to 3.7 USD, you needed to have the stock in your portfolio before the ex-date on 3/10/2026.

The last dividend was paid out on 3/12/2026.

In the year 2025, Novartis distributed 3.5 USD as dividends.

The dividends of Novartis are distributed in USD.

Dividend calendar 2026

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

All Key Metrics — Novartis